Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Refractory Graft Versus Host Disease”

121 trials

Showing 20 of 121 results

Early research (Phase 1)Temporarily pausedNCT05993611
What this trial is testing

Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Chronic Graft Versus Host DiseaseHematologic and Lymphocytic DisorderSteroid Refractory Graft Versus Host Disease
City of Hope Medical Center 27
Not applicableEnded earlyNCT02203578
What this trial is testing

Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Rutgers, The State University of New Jersey 1
Early research (Phase 1)Study completedNCT01155817
What this trial is testing

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Who this might be right for
Bone Marrow Transplant FailureLymphoma, Non-HodgkinLymphoma, T-Cell, Peripheral
Stanford University 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075225
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib

Who this might be right for
GVHDAcute Stem Cell Transplant Complications
Sichuan University 62
Testing effectiveness (Phase 2)Ended earlyNCT03422627
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease cGVHD
Amgen 32
Testing effectiveness (Phase 2)Looking for participantsNCT02918188
What this trial is testing

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft-versus-host Disease
Navy General Hospital, Beijing 21
Testing effectiveness (Phase 2)Study completedNCT00827398
What this trial is testing

Treatment of Steroid Resistant GVHD by Infusion MSC

Who this might be right for
Graft-versus-host-disease
N.M. Wulffraat 50
Not applicableLooking for participantsNCT06321198
What this trial is testing

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Anhui Provincial Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT01453140
What this trial is testing

In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus

Who this might be right for
Graft Versus Host Disease
Hackensack Meridian Health 3
Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Early research (Phase 1)WithdrawnNCT05443464
What this trial is testing

Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

Who this might be right for
GVHD,Acute
Ossium Health, Inc.
Early research (Phase 1)Study completedNCT03327857
What this trial is testing

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Who this might be right for
Steroid-refractory Acute Graft-versus-Host DiseaseTreatment-refractory Acute Graft-versus-Host Disease
AltruBio Inc. 37
Testing effectiveness (Phase 2)Study completedNCT00408928
What this trial is testing

Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease

Who this might be right for
Graft-versus-Host Disease
Sidney Kimmel Cancer Center at Thomas Jefferson University 11
Testing effectiveness (Phase 2)Study completedNCT00388362
What this trial is testing

Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease

Who this might be right for
Graft vs Host Disease
Stanford University 36
Early research (Phase 1)Ended earlyNCT04070781
What this trial is testing

Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Refractory GVHDGraft Vs Host Disease
Columbia University 1
Testing effectiveness (Phase 2)Ended earlyNCT00409695
What this trial is testing

Thymoglobulin (ATG) Dose Finding Study

Who this might be right for
Graft vs Host Disease
M.D. Anderson Cancer Center 1
Not applicableApproved For MarketingNCT05722912
What this trial is testing

Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Early research (Phase 1)Study completedNCT01911039
What this trial is testing

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

Who this might be right for
Graft Versus Host DiseaseAllogeneic Hematopoietic Cell Transplant Recipient
Laura Johnston 14
Large-scale testing (Phase 3)Ended earlyNCT04934670
What this trial is testing

Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

Who this might be right for
Steroid-Refractory Acute Graft Versus Host Disease
Xenikos 12
Early research (Phase 1)Study completedNCT01672229
What this trial is testing

Bortezomib in Patients With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Mehrdad Abedi, MD 16
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation